Establishment of in vitro genetically engineered cultures inScutellaria orientalisandS. araxensis

被引:3
|
作者
Gharari, Zahra [1 ]
Bagheri, Khadijeh [1 ]
Sharafi, Ali [2 ,3 ]
机构
[1] Univ Zanjan, Dept Plant Prod & Genet, Fac Agr, Zanjan, Iran
[2] Zanjan Univ Med Sci, Sch Pharm, Zanjan Pharmaceut Biotechnol Res Ctr, Zanjan, Iran
[3] Zanjan Univ Med Sci, Sch Pharm, Dept Pharmaceut Biotechnol, Zanjan, Iran
关键词
Agrobacterium rhizogenes; Genetically engineered cultures; rolB gene; Scutellaria; HAIRY ROOT CULTURES; RHIZOGENES-MEDIATED TRANSFORMATION; SCUTELLARIA-BAICALENSIS GEORGI; T-DNA DELIVERY; AGROBACTERIUM-RHIZOGENES; NEOCLERODANE DITERPENOIDS; ARTEMISININ PRODUCTION; ALKALOID PRODUCTION; PAPAVER-BRACTEATUM; IMMATURE EMBRYOS;
D O I
10.2478/s11756-020-00540-9
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Scutellaria orientalisandS. araxensisare perennial species of genusScutellaria(Lamiaceae) which produce some important pharmaceutical secondary metabolites. Four strains ofAgrobacterium rhizogenes(A4, A13, ATCC15834 and MSU440), three types of explant (stem, petiole and leaf), six concentrations of acetosyringone (25-150 mu M), two different co-cultivation methods (light and dark condition) and two co-cultivation media (full and half-strength MS) were used for optimization ofA. rhizogenesmediated transformation efficiency. Moreover, two inoculation approaches including immersion and injection as well as three infection period (5, 7 and 10 min) were examined. The molecular confirmation analysis of putative transgenic roots was performed by PCR using specific primers of therolB gene. The results revealed that the transformation efficiency was affected by bacterial strain, co-cultivation medium and type of explants. The highest transformation frequency of 93.3% was achieved on stem explants ofS. orientaliswith ATCC15834 strain, followed by MSU440, A13 and A4 with the frequency of 63.3%, 46.6% and 30%, respectively. InS. araxensis, the best transformation frequency of 76.6% and 43.3% were obtained on stem and petiole explants with MSU440 strain. 5 and 7 min for infection period significantly improved the transformation efficiency inS. orientalisandS. araxensisrespectively. Transformation rates of stem explants induced by ATCC15834, A4 and A13 strains were 53.3%, 36.6% and 20% respectively. Transformation frequency was significantly higher in half-strength MS, regardless ofA. rhizogenesstrains.
引用
收藏
页码:2383 / 2393
页数:11
相关论文
共 50 条
  • [31] Cofermentation of glucose, xylose, and arabinose by mixed cultures of two genetically engineered Zymomonas mobilis strains
    Mohagheghi, A
    Evans, K
    Finkelstein, M
    Zhang, M
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 1998, 70-2 (1) : 285 - 299
  • [32] Establishment of a bladder cancer syngeneic model using organoids from bladder epithelium in genetically engineered mice
    Hamada, Akihiro
    Kita, Yuki
    Sano, Takeshi
    Takada, Hideaki
    Nakamura, Kenji
    Sakatani, Toru
    Goto, Takayuki
    Akamatsu, Shusuke
    Kobayashi, Takashi
    CANCER SCIENCE, 2023, 114 : 244 - 244
  • [33] Establishment of a bladder cancer model using organoids derived from bladder epithelium in genetically engineered mice
    Hamada, Akihiro
    Kita, Yuki
    Takada, Hideaki
    Nakamura, Kenji
    Sakatani, Toru
    Sano, Takeshi
    Kobayashi, Takashi
    CANCER SCIENCE, 2022, 113
  • [34] VIRULENCE OF AND ESTABLISHMENT OF LATENCY BY GENETICALLY ENGINEERED DELETION MUTANTS OF HERPES-SIMPLEX VIRUS-1
    MEIGNIER, B
    LONGNECKER, R
    MAVROMARANAZOS, P
    SEARS, AE
    ROIZMAN, B
    VIROLOGY, 1988, 162 (01) : 251 - 254
  • [35] A genetically engineered, nonthrombogenic cellular lining for LVADs: In vitro preconditioning before in vivo implantation
    Vascular Cell Biology, Texas Heart Institute, Houston, TX, United States
    不详
    不详
    不详
    ASAIO J., 3 (172-177):
  • [36] Genetically Engineered Human Kidney Cells for Real-Time Cytotoxicity Testing In Vitro
    Miriam E. Mossoba
    Sanah N. Vohra
    Elmer Bigley
    Jessica Sprando
    Paddy L. Wiesenfeld
    Molecular Biotechnology, 2020, 62 : 252 - 259
  • [37] A genetically engineered, nonthrombogenic cellular lining for LVADs:: In vitro preconditioning before in vivo implantation
    Tock, CL
    Bosley, JP
    Parnis, SM
    Clubb, FJ
    Macris, MP
    Frazier, OH
    Scott-Burden, T
    ASAIO JOURNAL, 1999, 45 (03) : 172 - 177
  • [38] An in vitro assay to assess secreted osteogenic factors from genetically engineered cells.
    Viggeswarapu, M.
    Bargouti, M.
    Rogers, C.
    Titus, L.
    Boden, S. D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S240 - S241
  • [39] Genetically engineered pig red blood cells for clinical transfusion: initial in vitro studies
    Long, Cassandra
    Hara, Hidetaka
    Pawlikowski, Zachary
    Koike, Naoko
    d'Arville, Thomas
    Yeh, Peter
    Ezzelarab, Mohamed
    Ayares, David
    Yazer, Mark
    Cooper, David K. C.
    TRANSFUSION, 2009, 49 (11) : 2418 - 2429
  • [40] Genetically Engineered Human Kidney Cells for Real-Time Cytotoxicity Testing In Vitro
    Mossoba, Miriam E.
    Vohra, Sanah N.
    Bigley, Elmer, III
    Sprando, Jessica
    Wiesenfeld, Paddy L.
    MOLECULAR BIOTECHNOLOGY, 2020, 62 (04) : 252 - 259